EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A new hyaluronate gel spacer and injection technique for cervical cancer brachytherapy: a technical report

Yusaku Miyata iD, Etsuyo Ogo iD, Kenta Murotani iD, Kazuya Nagahiro iD, Kento Hoshida iD, Naotake Tsuda iD, Shin Nishio iD, Gaku Shioyama iD, Nona Fujimoto iD, Tetsuo Yamasaki iD, Ryosuke Akeda iD, Koichiro Muraki iD und 3 weitere

Journal of Radiation Research · 2025

DOI: 10.1093/jrr/rraf055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radiation Research, 2025. Verfasst von Yusaku Miyata und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, School of Medicine, Kurume University, 67 Asahimachi, Kurume City, Fukuoka 830-0011, Japan. Hauptthemen laut MEDLINE: Hyaluronic Acid, Brachytherapy, Uterine Cervical Neoplasms. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spacers separating the tumor from adjacent organs help improve irradiation dose parameters. We introduce a new hyaluronate gel spacer with MEIJI (ADANT®) as an alternative to the previously used Suvenyl® and its injection technique for cervical cancer brachytherapy. Five patients with cervical cancer underwent hyaluronate gel injection (HGI) with the MEIJI hyaluronate gel in their rectovaginal and vesicovaginal septa. The minimum doses covering 90% of the high-risk clinical target volume (CTVHRD90%), the most exposed 2 cc (D2cc) of organs at risk per session, as well as the total doses for combined external beam radiotherapy (with a central shield) and brachytherapy, were assessed. The median CTVHRD90% was 9.3 (range, 6.4–9.7) Gy per session and 92.2 Gy in the equivalent dose in 2 Gy fractions (EQD2) (80.3–93.3 Gy-EQD2) overall. The median rectum D2cc was 2.9 (1.8–5.0) Gy per session and 45.4 (43.4–57.1) Gy-EQD2 overall. The median D2cc of the bladder (bladder D2cc) was 4.8 (2.4–6.5) Gy per session and 64.6 (62.3–69.6) Gy-EQD2 overall. The MEIJI spacer disappeared within 3 or 7 days with no adverse events associated with HGI or deterioration of the patients’ quality of life. MEIJI HGI facilitates a sufficient CTVHRD90% while keeping the rectal and bladder D2cc within dose constraints, even when the rectum and bladder are in close proximity to the CTVHR. In conclusion, the MEIJI spacer may help appropriately meet dose constraints, thereby potentially contributing to improving local control and/or reducing adverse events for patients receiving radiotherapy for cervical cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidBrachytherapyUterine Cervical NeoplasmsHumansFemaleGelsMiddle AgedRadiotherapy DosageInjectionsAgedAdult

Stichwörter der Autor:innen

ADANT®MEIJIbrachytherapycervical cancerhyaluronate gel injectionspacer

Substanzen

Hyaluronic AcidGels

Autor:innen und Institutionen

  • Department of Radiology, School of Medicine, Kurume University, 67 Asahimachi, Kurume City, Fukuoka 830-0011, Japan.
  • Kurume University School of Medical Technology, 777-1 Higashikushiharamachi, Kurume City, Fukuoka 830-0003, Japan.
  • Biostatistics Center, Kurume University, 67 Asahimachi, Kurume City, Fukuoka 830-0011, Japan.
  • Department of Radiology, Kurume University Hospital, 67 Asahimachi, Kurume City, Fukuoka 830-0011, Japan.
  • Department of Obstetrics and Gynecology, School of Medicine, Kurume University, 67 Asahimachi, Kurume City, Fukuoka 830-0011, Japan.

ORCID-Profile: Yusaku Miyata, Etsuyo Ogo, Kenta Murotani, Kazuya Nagahiro, Kento Hoshida, Naotake Tsuda, Shin Nishio, Gaku Shioyama, Nona Fujimoto, Tetsuo Yamasaki, Ryosuke Akeda, Koichiro Muraki, Chiyoko Tsuji, Chikayuki Hattori, Shuichi Tanoue

Zitieren

APA

Miyata, Y., Ogo, E., Murotani, K., Nagahiro, K., Hoshida, K., Tsuda, N., Nishio, S., Shioyama, G., Fujimoto, N., Yamasaki, T., Akeda, R., Muraki, K., Tsuji, C., Hattori, C., & Tanoue, S. (2025). A new hyaluronate gel spacer and injection technique for cervical cancer brachytherapy: a technical report. Journal of Radiation Research. https://doi.org/10.1093/jrr/rraf055

Vancouver

Miyata Y, Ogo E, Murotani K, Nagahiro K, Hoshida K, Tsuda N, et al. A new hyaluronate gel spacer and injection technique for cervical cancer brachytherapy: a technical report. Journal of Radiation Research. 2025. doi:10.1093/jrr/rraf055

BibTeX
@article{Miyata2025,
  author = {Miyata, Yusaku and Ogo, Etsuyo and Murotani, Kenta and Nagahiro, Kazuya and Hoshida, Kento and Tsuda, Naotake and Nishio, Shin and Shioyama, Gaku and Fujimoto, Nona and Yamasaki, Tetsuo and Akeda, Ryosuke and Muraki, Koichiro and Tsuji, Chiyoko and Hattori, Chikayuki and Tanoue, Shuichi},
  title = {A new hyaluronate gel spacer and injection technique for cervical cancer brachytherapy: a technical report},
  journal = {Journal of Radiation Research},
  year = {2025},
  doi = {10.1093/jrr/rraf055}
}
Kostenlos starten →